AnaptysBio Stock Options
| ANAB Stock | USD 38.48 0.95 2.53% |
AnaptysBio's latest option contracts expiring on 2024-10-18 have a put-to-call open interest ratio of 0.02 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-10-18. The AnaptysBio option chain provides detailed quote and price information for the current AnaptysBio option contracts. It shows all of AnaptysBio's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-10-18 Option Contracts
2024-10-18
The chart above shows AnaptysBio's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. AnaptysBio's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for AnaptysBio's option, there is no secondary market available for investors to trade.
AnaptysBio's option chain provides insight into all available option contracts written on AnaptysBio's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of AnaptysBio's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given AnaptysBio option contract.
In The Money vs. Out of Money Option Contracts on AnaptysBio
Analyzing AnaptysBio's in-the-money options over time can help investors to take a profitable long position in AnaptysBio regardless of its overall volatility. This is especially true when AnaptysBio's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money AnaptysBio's options could be used as guardians of the underlying stock as they move almost dollar for dollar with AnaptysBio's stock while costing only a fraction of its price.
AnaptysBio's stock options are financial instruments that give investors the right to buy or sell shares of AnaptysBio common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell AnaptysBio stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If AnaptysBio's stock price goes up or down, the stock options follow.
At present, AnaptysBio's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Capital Stock is expected to grow to about 30.2 K, whereas Total Stockholder Equity is forecasted to decline to about 83.7 M. AnaptysBio Current Options Market Mood
AnaptysBio's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps AnaptysBio Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of AnaptysBio's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. AnaptysBio's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current AnaptysBio's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current AnaptysBio contract
Base on the Rule 16, the options market is currently suggesting that AnaptysBio will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-10-18 option contract. With AnaptysBio trading at USD 38.48, that is roughly USD 0.0. If you think that the market is fully incorporating AnaptysBio's daily price movement you should consider buying AnaptysBio options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
AnaptysBio |
Purchasing AnaptysBio options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" AnaptysBio calls. Remember, the seller must deliver AnaptysBio stock to the call owner when a call is exercised.
AnaptysBio Option Chain
When AnaptysBio's strike price is surpassing the current stock price, the option contract against AnaptysBio stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
AnaptysBio's option chain is a display of a range of information that helps investors for ways to trade options on AnaptysBio. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for AnaptysBio. It also shows strike prices and maturity days for a AnaptysBio against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-10-18 CALL at $17.5 | 0.9743 | 0.0034 | 0 | 2024-10-18 | 19.0 - 23.5 | 0.0 | In |
Call | 2024-10-18 CALL at $20.0 | 0.9706 | 0.0045 | 0 | 2024-10-18 | 16.5 - 21.0 | 0.0 | In |
Call | 2024-10-18 CALL at $22.5 | 0.9663 | 0.006 | 0 | 2024-10-18 | 14.0 - 18.5 | 0.0 | In |
Call | 2024-10-18 CALL at $25.0 | 0.928 | 0.0106 | 0 | 2024-10-18 | 12.1 - 16.0 | 13.75 | In |
Call | 2024-10-18 CALL at $30.0 | 0.8701 | 0.0218 | 0 | 2024-10-18 | 7.1 - 11.5 | 0.0 | In |
Call | 2024-10-18 CALL at $35.0 | 0.7194 | 0.0425 | 65 | 2024-10-18 | 3.6 - 6.7 | 4.6 | In |
Put | 2024-10-18 PUT at $40.0 | -0.5427 | 0.0568 | 0 | 2024-10-18 | 1.8 - 5.4 | 0.0 | In |
Put | 2024-10-18 PUT at $45.0 | -0.7832 | 0.0433 | 0 | 2024-10-18 | 5.1 - 9.3 | 0.0 | In |
Put | 2024-10-18 PUT at $50.0 | -0.8643 | 0.0264 | 0 | 2024-10-18 | 9.9 - 14.0 | 0.0 | In |
Put | 2024-10-18 PUT at $55.0 | -0.9398 | 0.0145 | 0 | 2024-10-18 | 14.8 - 18.5 | 0.0 | In |
AnaptysBio Total Stockholder Equity
Total Stockholder Equity |
|
AnaptysBio Corporate Management
| Martin Dahl | Senior Research | Profile | |
| Monique Silva | Senior Affairs | Profile | |
| James MD | Advisor | Profile | |
| Beth Mueller | Senior Resources | Profile | |
| Priya Raina | Senior Operations | Profile | |
| Eric Loumeau | General Counsel | Profile | |
| FAAD MBA | Chief Officer | Profile |
Additional Information and Resources on Investing in AnaptysBio Stock
When determining whether AnaptysBio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnaptysBio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anaptysbio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anaptysbio Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnaptysBio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade AnaptysBio Stock refer to our How to Trade AnaptysBio Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnaptysBio. If investors know AnaptysBio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnaptysBio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.35) | Revenue Per Share 1.136 | Quarterly Revenue Growth 2.171 | Return On Assets (0.21) | Return On Equity (2.15) |
The market value of AnaptysBio is measured differently than its book value, which is the value of AnaptysBio that is recorded on the company's balance sheet. Investors also form their own opinion of AnaptysBio's value that differs from its market value or its book value, called intrinsic value, which is AnaptysBio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnaptysBio's market value can be influenced by many factors that don't directly affect AnaptysBio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnaptysBio's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnaptysBio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnaptysBio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.